A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Trial details
- Registry ID
- NCT06628947
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaNCT06628947 | KPRX | Phase 2 | Recruiting | 2027-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |